Cargando…

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates

Metastatic urothelial cancer, associated with a poor prognosis, is still major cause of cancer-related death, with scarce options of effective treatment after progression to platinum-based chemotherapy and immunotherapy. The human epithelial growth factor receptor 2 (Her-2) has been identified as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albarrán, Víctor, Rosero, Diana Isabel, Chamorro, Jesús, Pozas, Javier, San Román, María, Barrill, Ana María, Alía, Víctor, Sotoca, Pilar, Guerrero, Patricia, Calvo, Juan Carlos, Orejana, Inmaculada, Pérez de Aguado, Patricia, Gajate, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603928/ https://www.ncbi.nlm.nih.gov/pubmed/36293515 http://dx.doi.org/10.3390/ijms232012659

Ejemplares similares

Recurrent Glioblastoma: A Review of the Treatment Options
por: Vaz-Salgado, Maria Angeles, et al.
Publicado: (2023)

Current Landscape of Immunotherapy for Advanced Sarcoma
por: Albarrán, Víctor, et al.
Publicado: (2023)

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas
por: Albarrán, Víctor, et al.
Publicado: (2022)

Novel Tyrosine Kinase Targets in Urothelial Carcinoma
por: Torres-Jiménez, Javier, et al.
Publicado: (2021)

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
por: San-Román-Gil, María, et al.
Publicado: (2023)

Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
por: Albarrán, Víctor, et al.
Publicado: (2022)

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature
por: Guerrero, Patricia, et al.
Publicado: (2023)

Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain †
por: Cruz, Victor L., et al.
Publicado: (2023)

Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022)

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature
por: Albarrán, Víctor, et al.
Publicado: (2023)

Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report
por: Albarrán, Víctor, et al.
Publicado: (2021)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
por: Faiena, Izak, et al.
Publicado: (2018)

The importance of early identification of infusion-related reactions to monoclonal antibodies
por: Cáceres, Macarena C, et al.
Publicado: (2019)

Monoclonal Antibody-Based Therapies for Myasthenia Gravis
por: Alabbad, Sawsan, et al.
Publicado: (2020)

Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
por: Yu, Shengnan, et al.
Publicado: (2017)

Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors
por: Denlinger, Crystal S., et al.
Publicado: (2021)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report
por: Alía Navarro, Víctor, et al.
Publicado: (2023)

Clinical development of immunotherapies for HER2(+) breast cancer: a review of HER2-directed monoclonal antibodies and beyond
por: Costa, Ricardo L. B., et al.
Publicado: (2020)

Engineering the supernatural: monoclonal antibodies for challenging infectious diseases
por: Grace, Patricia S, et al.
Publicado: (2022)

Impact of IgG subclass on monoclonal antibody developability
por: Cain, Paul, et al.
Publicado: (2023)

Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties
por: Miranda, Ana Cláudia Camargo, et al.
Publicado: (2021)

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
por: Gogesch, Patricia, et al.
Publicado: (2021)

Monoclonal Antibodies in Cancer
por: Ghosh, A.K.
Publicado: (1986)

Pharmacokinetics of Monoclonal Antibodies
por: Ryman, Josiah T., et al.
Publicado: (2017)

Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2009)

Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
por: Ceran, Ceyhan, et al.
Publicado: (2012)

The pharmacology and therapeutic applications of monoclonal antibodies
por: Castelli, María Sofía, et al.
Publicado: (2019)

Microbials for the production of monoclonal antibodies and antibody fragments
por: Spadiut, Oliver, et al.
Publicado: (2014)

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
por: Chamorro, Sonia, et al.
Publicado: (2014)

Tyrosine Kinase Receptors in Oncology
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2020)

Impact of IgG subclass on molecular properties of monoclonal antibodies
por: Tang, Yu, et al.
Publicado: (2021)

Body Mass Index Influence for the Personalization of the Monoclonal Antibodies Therapy for Psoriasis
por: Anghel, Flavia, et al.
Publicado: (2021)

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
por: Caronna, Edoardo, et al.
Publicado: (2021)

Epitope Mapping of Human HER2 Specific Mouse Monoclonal Antibodies Using Recombinant Extracellular Subdomains
por: Ghatar, Reza Hosseini, et al.
Publicado: (2017)

Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways
por: Soltantoyeh, Tahereh, et al.
Publicado: (2018)

Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma
por: Asano, Teizo, et al.
Publicado: (2021)

Human sperm carbohydrate antigens defined by an antisperm human monoclonal antibody derived from an infertile woman bearing antisperm antibodies in her serum
Publicado: (1988)

Quantitation of monoclonal antibody by capture ELISA based on initial enzyme activity rate
por: Domínguez, Mercedes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6g3t3306vt5du712ps4nj9atou